BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• Press Releases

  Biocon Biologics Announces Positive Results from Phase 3 Study of Yesintek™ Biosimilar to Ustekinumab for Chronic Plaque Psoriasis

  March 10, 2025

   · 

  7 min read
• Press Releases

  Acurx Pharmaceuticals, Inc. Announces $1.1 Million Registered Direct Offering

  March 10, 2025

   · 

  6 min read
• Press Releases

  PDS Biotech Initiates VERSATILE-003 Phase 3 Clinical Trial Evaluating Versamune® HPV in HPV16-Positive Head and Neck Cancer

  March 10, 2025

   · 

  6 min read
• Press Releases

  ACARIZAX® approved in Canada for treatment of young children

  March 10, 2025

   · 

  2 min read
• Press Releases

  Achieve Life Sciences to Present at the Barclays 27th Annual Global Healthcare Conference

  March 10, 2025

   · 

  5 min read
• Press Releases

  Waters Corporation to Present at the Leerink Partners Global Healthcare Conference

  March 10, 2025

   · 

  1 min read
• Press Releases

  Diabetes Research Institute Welcomes Dr. Dirk Homann to Esteemed Team of Scientists Leading Cure-Focused Diabetes Research

  March 10, 2025

   · 

  3 min read
• Press Releases

  Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - March 7, 2025

  March 10, 2025

   · 

  2 min read
• Press Releases

  Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 7, 2025

  March 10, 2025

   · 

  1 min read
• Press Releases

  Alberta sets a new standard for advanced prostate cancer treatment with public reimbursement of Pluvicto™

  March 10, 2025

   · 

  4 min read